Amanda S. Machado

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection

Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel Dias et al. · npj Vaccines · 2020 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis

Áquila S.B. Portela, Lourena E. Costa, Beatriz C.S. Salles et al. · Immunobiology · 2017 · 40 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

A clioquinol-containing Pluronic^® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model

Grasiele S.V. Tavares, Débora V.C. Mendonça, Isabela A.G. Pereira et al. · Parasite · 2020 · 30 citations · Full text

Veterinary Medicine, Infectious Diseases, Medicinal Chemistry +16

Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans

Thaís T.O. Santos, Mariana Santos Cardoso, Amanda S. Machado et al. · Microbial Pathogenesis · 2019 · 29 citations

Veterinary Medicine, Infectious Diseases, Veterinary Parasitology +13

A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection

Daniela P. Lage, Danniele L. Vale, Flávia P. Linhares et al. · Vaccines · 2022 · 29 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17